StockData
AVDNYSEAgricultural ChemicalsFiscal year ends December 31

AMERICAN VANGUARD CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-K/A on Sep 30, 2026
$1.07+0.01 (+0.94%)

Close on Oct 19, 2026

Market cap
$30.65M
P/E (TTM)
–
Dividend yield
–

About American Vanguard

Agricultural Chemicals, SIC 2870

American Vanguard Corporation develops, manufactures, and markets chemical, biological, and biorational solutions for agricultural, commercial, and consumer applications. The company operates through a single reportable segment, synthesizing active ingredients and formulating products such as insecticides, fungicides, herbicides, soil health treatments, plant nutrition aids, molluscicides, growth regulators, and soil fumigants. It also offers specialized closed delivery systems for product application. The business serves growers, retailers, and end-users, primarily selling to national distribution firms, agricultural buying groups, and cooperatives.

The company operates six manufacturing facilities, consisting of four chemical synthesis and formulation sites alongside two biological fermentation plants located in the United States and Mexico. Beyond domestic operations, it maintains sales offices, wholly owned distributors, or commercial agents across Central and South America, Australia, New Zealand, and India. American Vanguard Corporation is incorporated in Delaware and maintains its principal executive headquarters in Newport Beach, California.

Summary of the business section of American Vanguard's latest annual report, written by StockData.

Company profile

Company

Legal name
AMERICAN VANGUARD CORP
Founded
1969
Headquarters
Newport Beach, CA
Address
4695 Macarthur Court 92660
Phone
(949) 260-1200
Employees
739, Dec 31, 2025
Industry
Agricultural Chemicals
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Costa Mesa, California

Stock & identifiers

Ticker
AVD
Exchange
NYSE
Shares outstanding
29M, Feb 20, 2026
Public float
$111.10M, Jun 30, 2025
Filer category
Accelerated filer
Stock splits
4-for-3, Apr 18, 2006; 2-for-1, Apr 18, 2005; 3-for-2, Apr 19, 2004; 3-for-2, Apr 14, 2003; 4-for-3, Apr 15, 2002; 11-for-10, Mar 28, 2001; 11-for-10, Mar 29, 2000; 5-for-4, Nov 2, 1988
SEC CIK
5981
CUSIP
030371108
ISIN
US0303711081
LEI
529900GWI78WZA5M9783
EIN
95-2588080

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Douglas KayeCHIEF EXECUTIVE OFFICER306,778
David` T. JohnsonSee Remarks71,671
Jared StraleySVP Operations & Supply Chain10,000
Timothy J. DonnellySee Remarks85,102
Michael Joseph DiPaolaChief Commercial Officer10,000
Nolteanous GilliamSVP Manufacturing4,245
Shirin KhosraviCHRO4,377
Peter EilersSee Remarks32,177
Keith M. RosenbloomDirector638,064
Steven D. MacicekDirector99,711
Rubin J. McDougalDirector31,872
Mark R. BassettDirector89,919
Patrick E. GottschalkDirector223,577
Marisol AngeliniDirector68,762
de Mino Carmen TiuDirector24,407
Emer GunterDirector33,723
Scott BaskinDirector41,997

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Douglas A. Kaye
$1.07M$770.73K$585.24K$25$119
FY2025
Douglas AKaye
$1.07M$770.73K$585.24K$25$119
FY2024
Douglas A. Kaye
$1.68M$339.58K$680.44K$24$113
FY2024
Douglas AKaye
$1.68M$339.58K$680.44K$24$113
FY2023
Douglas A. Kaye
$2.51M-$471.65K$567.67K$72$105
FY2023
Eric GWintemute
$2.51M-$471.65K$567.67K$72$105

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“The Company employed 739 employees as of December 31, 2025.”

Corporate history

Events identified from SEC filings